期刊
JOURNAL OF PHARMACEUTICAL SCIENCES
卷 101, 期 3, 页码 1178-1188出版社
ELSEVIER SCIENCE INC
DOI: 10.1002/jps.23024
关键词
electrospray; nanocrystal; crystallization; polymorphism; continuous pharmaceutical manufacturing; controlled release; nanoparticles; nanotechnology
资金
- Novartis through the MIT-Novartis Center for Continuous Manufacturing
In this paper, an electrospray technique followed by annealing at high temperatures was developed to produce nanocrystals of carbamazepine (CBZ), a poorly water-soluble drug, for continuous pharmaceutical manufacturing process. Electrospraying solutions of CBZ in methanol obeys the expected scaling law of current, which is I similar to Q(1/2) (I, electrical current; Q, flow rate), for liquids with sufficiently high conductivity and viscosity. Lower flow rates during electrospraying were preferred to produce smaller diameters of monodisperse, dense CBZ nanoparticles. CBZ nanoparticles were predominantly amorphous immediately after electrospraying. Crystallization of CBZ nanoparticles was accelerated by annealing at high temperatures. CBZ nanocrystals with the most stable polymorph, form III, were obtained by annealing at 90 degrees C, which is above the transition temperature, 78 degrees C, for the enantiotropic CBZ form III and form I. The solubility and dissolution rates of CBZ nanocrystals increased significantly as compared with those of CBZ bulk particles. Therefore, electrospray technology has the potential to produce pharmaceutical dosage forms with enhanced bioavailability and can readily be integrated in a continuous pharmaceutical manufacturing process. (c) 2011 Wiley Periodicals, Inc. and the American Pharmacists Association J Pharm Sci 101:11781188, 2012
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据